Infostream
Jan 29, 2026

New York AG Orders NYU Langone to Reinstate Transgender Youth Treatments, Citing State Law Violations

Letitia James speaking in press conference

New York — Letitia James has directed NYU Langone Health to resume providing gender-transition treatments to transgender patients under 19, arguing that the hospital system’s recent suspension of its Transgender Youth Health Program violates New York’s anti-discrimination statutes.

In a Feb. 25 letter made public this week, the attorney general’s office stated that NYU Langone’s decision to discontinue the program jeopardized access to medically necessary healthcare for a vulnerable population and could constitute unlawful discrimination under state law.

The dispute places one of New York City’s largest hospital systems at the center of an intensifying national legal and political battle over transgender healthcare for minors — a debate increasingly shaped by federal policy shifts under President Donald Trump.

Hospital’s Decision Followed Federal Funding Threats

NYU Langone announced last month that it would stop providing certain gender-transition treatments — including hormone therapies and puberty blockers — to patients under 19.

In a statement at the time, hospital spokesperson Steve Ritea cited the departure of the program’s medical director and what he described as a rapidly changing regulatory environment.

“Given the recent departure of our medical director, coupled with the current regulatory environment, we made the difficult decision to discontinue our Transgender Youth Health Program,” Ritea said. He added that pediatric mental health services would continue and that the hospital was working to support affected families during the transition.

The move came after President Trump signed an executive order titled “Protecting Children from Chemical and Surgical Mutilation,” aimed at restricting gender-transition procedures for minors. Subsequently, the U.S. Department of Health and Human Services signaled it would pursue measures to cut federal Medicaid and Medicare funding to hospitals that provide such treatments.

While the proposal raised concern among healthcare providers nationwide, New York officials maintain that no formal change in federal law has occurred.

State Law vs. Federal Policy

In the letter to NYU Langone, Darsana Srinivasan, chief of the attorney general’s Health Care Bureau, wrote that federal funding proposals do not override existing obligations under New York law.

“The proposal does not alter a medical institution’s existing duties and obligations under New York law,” Srinivasan wrote, adding that the abrupt discontinuation of transgender healthcare services could have severe negative health consequences.

Other posts